Discover the in’s and out’s of our solutions in a private demo
India
In 2023, India reported a slight decrease in TB cases compared to the previous year. Drug-resistant TB continued to pose a serious challenge, with an estimated 110,000 cases.
2.8 million people
developed TB
320,000 people
died from the disease
417,286 cases
were undiagnosed or unreported
Our work in India
Over the year, we have contributed to multiple research-focused projects in India, primarily involving the deployment of CAD4TB. This initiative enabled AI-powered screening closer to communities with high TB prevalence and limited access to diagnostic services.
2017
1 CAD4TB was delivered to the Medanta Duke Research Institute to support TB screening.
2021
We implemented CAD4TB in four districts of Karnataka—Bidar, Yadgir, Gulbarga, and Bijapur—in collaboration with our local partner.
Connect with our representative in your country.
We work alongside Ministries of Health, implementing partners, and healthcare providers to ensure solutions are aligned with national strategies and local healthcare systems.
- Review which solutions align with your programmatic and operational needs
- Explore partnership opportunities and long-term collaboration
- Address technical, clinical, and infrastructure considerations specific to your setting